Zimmer Biomet
0.83 %
-16.04 %
Yet to be announced
Company Overview
Zimmer Biomet Holdings, Inc. operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products.
Revenue Sources
PassAnalyzing Zimmer Biomet's revenue sources, the company generates its income primarily from medical devices, surgical instruments, and orthopedic implants. These products and services are halal as they serve essential medical purposes and contribute to human wellbeing. There is no evidence of revenue from prohibited sources such as alcohol, gambling, or other haram activities.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 31, 2025 | $1.91b | $1.68b | - | $66.2m | 0.00% | 3.93% |
| Dec. 31, 2024 | $2.02b | $1.7b | - | $61.9m | 0.00% | 3.65% |
| Sept. 30, 2024 | $1.82b | $1.6b | - | $54.3m | 0.00% | 3.40% |
| June 30, 2024 | $1.94b | $1.64b | - | $51.1m | 0.00% | 3.11% |
For the last four quarters, the company's interest expense to total expense ratios have remained consistently low. The interest expenses relative to total expenses have stayed below the 5% threshold that we consider material. The company's operational model is clearly focused on manufacturing and selling medical devices rather than financial activities.
Operational Ethics
PassBased on available information from SEC filings and company disclosures, there is no evidence of significant ongoing associations with entities involved in human rights violations. While the company operates globally, there are no documented substantial ties to the Israeli state or direct involvement with the Chinese Communist Party that would raise concerns.
Comments